MedPath
NMPA Approval

Belumosudil Mesylate Tablets

国药准字HJ20230095

August 1, 2023

Drug Information

甲磺酸贝舒地尔片

易来克

片剂

0.2 g(按C₂₆H₂₄N₆O₂计)

化学药品

August 1, 2023

July 31, 2028

Company Information

Applicant Company

55 Corporate Drive, Bridgewater, NJ 08807 United States of America

Manufacturing Company

501 Fifth Street, Bristol, TN 37620 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸贝舒地尔片 - NMPA 批准文号 | MedPath